University of Minnesota. Driven to Discover.
In a sample from a patient who died, researchers saw signs that the H7N9 virus had started to mutate to a form resistant to Tamiflu.
Though deep cuts aren't likely to be enacted, health groups and experts aired strong concerns.
Some topics: weighing risks and benefits, ethical issues, and global involvement.
In addition to recent problems with anthrax and smallpox, high-path avian flu has now entered the mix.
A new molecular strategy could diffuse some of the controversy over lab-modified flu viruses.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.